doi: 10.1086/591456.
Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units
Affiliations
- PMID: 18837670
- DOI: 10.1086/591456
Item in Clipboard
Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units
Infect Control Hosp Epidemiol.
2008 Nov.
Abstract
A retrospective, propensity-matched cohort study was conducted to determine the mortality rate in patients with healthcare-associated infection (HAI) due to multidrug-resistant (MDR) Acinetobacter baumannii. The 28-day mortality rate for patients with MDR A. baumannii HAI was not significantly different than that for patients with non-MDR A. baumannii HAI. The median length of hospital stay before diagnosis of HAI was 4.5 days longer for patients with MDR A. baumannii infection than for patients with non-MDR A. baumannii infection (P < .001).
Similar articles
-
Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.Ann Pharmacother. 2006 Nov;40(11):1939-45. doi: 10.1345/aph.1H353. Epub 2006 Oct 3. Ann Pharmacother. 2006. PMID: 17018688
-
Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.Infect Control Hosp Epidemiol. 2007 Jun;28(6):713-9. doi: 10.1086/517954. Epub 2007 May 14. Infect Control Hosp Epidemiol. 2007. PMID: 17520546
-
Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.Surg Infect (Larchmt). 2007 Aug;8(4):437-43. doi: 10.1089/sur.2006.029. Surg Infect (Larchmt). 2007. PMID: 17883360
-
[Multidrug resistant Acinetobacter baumanii:clinical update and new highlights].Rev Esp Quimioter. 2010 Mar;23(1):12-9. Rev Esp Quimioter. 2010. PMID: 20232019 Review. Spanish.
-
Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis.J Hosp Infect. 2024 Jul;149:77-87. doi: 10.1016/j.jhin.2024.04.013. Epub 2024 May 6. J Hosp Infect. 2024. PMID: 38710306 Review.
Cited by
-
Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based matched cohort study.PLoS One. 2023 Sep 11;18(9):e0291059. doi: 10.1371/journal.pone.0291059. eCollection 2023. PLoS One. 2023. PMID: 37695791 Free PMC article.
-
Acinetobacter baumannii infection in a medical intensive care unit: The impact of strict infection control.Afr J Thorac Crit Care Med. 2019 Apr 12;25(1):10.7196/AJTCCM.2019.v25i1.239. doi: 10.7196/AJTCCM.2019.v25i1.239. eCollection 2019. Afr J Thorac Crit Care Med. 2019. PMID: 34286240 Free PMC article.
-
Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia.J Intensive Care. 2015 Mar 2;3:9. doi: 10.1186/s40560-015-0077-4. eCollection 2015. J Intensive Care. 2015. PMID: 27408726 Free PMC article.
-
Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.World J Crit Care Med. 2016 May 4;5(2):111-20. doi: 10.5492/wjccm.v5.i2.111. eCollection 2016 May 4. World J Crit Care Med. 2016. PMID: 27152254 Free PMC article. Review.
-
Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia.Ann Thorac Med. 2015 Oct-Dec;10(4):256-62. doi: 10.4103/1817-1737.164302. Ann Thorac Med. 2015. PMID: 26664563 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
